Wealthfront Advisers LLC

SEC CIK: 0001763921
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

DNA holding history

Ginkgo Bioworks Holdings, Inc. in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNA overview All 13F holders of DNA Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2022

Holdings of DNA by Wealthfront Advisers LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−16,936−100.0%	Sold out	Holders
Q3 2022	16,936	$53.0K	<0.1%	−16,633−49.5%	Reduced	Holders
Q2 2022	33,569	$80.0K	<0.1%	+33,569	New	Holders